- Home
- PROK vs FRST Comparison
PROK vs FRST Comparison
Compare PROK & FRST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROK
- FRST
- Stock Information
- Founded
- PROK 2015
- FRST 2004
- Country
- PROK United States
- FRST United States
- Employees
- PROK N/A
- FRST N/A
- Industry
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- FRST Major Banks
- Sector
- PROK Health Care
- FRST Finance
- Exchange
- PROK Nasdaq
- FRST Nasdaq
- Market Cap
- PROK 334.8M
- FRST 273.3M
- IPO Year
- PROK N/A
- FRST 2006
- Fundamental
- Price
- PROK $3.11
- FRST $10.68
- Analyst Decision
- PROK Buy
- FRST Buy
- Analyst Count
- PROK 5
- FRST 1
- Target Price
- PROK $6.25
- FRST $420.00
- AVG Volume (30 Days)
- PROK 2.5M
- FRST 82.5K
- Earning Date
- PROK 11-11-2025
- FRST 10-23-2025
- Dividend Yield
- PROK N/A
- FRST 3.76%
- EPS Growth
- PROK N/A
- FRST N/A
- EPS
- PROK N/A
- FRST 0.11
- Revenue
- PROK $527,000.00
- FRST $127,561,000.00
- Revenue This Year
- PROK $338.06
- FRST $13.42
- Revenue Next Year
- PROK N/A
- FRST $13.48
- P/E Ratio
- PROK N/A
- FRST $95.86
- Revenue Growth
- PROK N/A
- FRST 19.27
- 52 Week Low
- PROK $0.46
- FRST $7.59
- 52 Week High
- PROK $7.13
- FRST $12.95
- Technical
- Relative Strength Index (RSI)
- PROK 54.93
- FRST 45.91
- Support Level
- PROK $2.34
- FRST $10.27
- Resistance Level
- PROK $3.02
- FRST $10.78
- Average True Range (ATR)
- PROK 0.17
- FRST 0.22
- MACD
- PROK 0.03
- FRST -0.00
- Stochastic Oscillator
- PROK 65.59
- FRST 42.53
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.
About FRST Primis Financial Corp.
Primis Financial Corp is the bank holding company for Primis Bank, providing financial services to individuals and small and medium-sized businesses. Primis Bank offers a wide range of commercial banking services, It focuses on making loans secured mainly by commercial real estate and other types of secured and unsecured commercial loans to small and medium-sized businesses in several industries, as well as loans to individuals for a variety of purposes. Primis Bank offers a broad range of deposit products, including checking (NOW), savings, money market accounts, and certificates of deposit. Its operating segments are Primis Mortgage, Primis Bank, and Other.